REFERENCES
- Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson DM, Korszun A. Replacement medication for cocaine dependence: methylphenidate. J Clin Pharmacol 1997; 20(3):485–488. [CSA]
- Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzsk LA, Creson D, Moeller FG. Dextroamphetamine for cocaine-dependence treatment: a double-blind, randomized clinical trial. J Clin Pharmacol 2001; 21(5):522–526. [CSA]
- Levin FR, Evans SM, McDowell DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention deficit hyperactivity disorder: a pilot study. J Clin Psychiatry 1998; 59:300–305. [INFOTRIEVE], [CSA]
- Provigil® (modafinil) Package Insert. Cephalon, Inc.; West Chester, PA. Available at http://www.provigil.com. 2004. [CSA]
- Ferraro L, Antonelli T, O'Connor WT, Tanganelli S, Rambert FA, Fuxe K. The effects of modafinil on striatal, pallidal, and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neuroscience Lett 1998; 253:135–138. [CSA], [CROSSREF]
- Perez de la Mora M, Aguilar-Garcia A, Ramon-Frias T, Ramirez-Ramirez R, Mendez-Franco J, Rambert F, Fuxe K. Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus. Neurosci Lett 1999; 259:181–185. [INFOTRIEVE], [CSA], [CROSSREF]
- Mignot E, Nishino S, Guilleminault C, Dement WC. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994; 17(5):436–437. [INFOTRIEVE], [CSA]
- Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21(5):1787–1794. [INFOTRIEVE], [CSA]
- Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA 1996; 98(24):14128–14133. [CSA], [CROSSREF]
- Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neurosci Lett 1998; 241(2–3):95–98. [INFOTRIEVE], [CSA], [CROSSREF]
- Scammel TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000; 20(22):8620–8628. [CSA]
- Dackis CA, Lynch KG, Yu E, Samaha FF, Kampman KM, Cornish JW, Rowan A, Poole S, White L, O'Brien CP. Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 2003; 70(1):29–37. [INFOTRIEVE], [CSA], [CROSSREF]
- Donovan JL, DeVane CL, Malcolm RJ, Mojsiak J, Chiang CN, Elkashef A, Taylor RM. Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet 2005; 44(7):753–765. [INFOTRIEVE], [CSA], [CROSSREF]
- Bernards CM, Cullen BF, Powers KM. Effects of chronic cocaine exposure on the hemodynamic response to vasopressors in sheep. J Trauma Injury Infection Crit Care 1997; 45:680–686. [CSA], [CROSSREF]
- Wong YN, Wang L, Hartman L, Simcoe D, Chen Y, Laughton WB, Eldon R, Markland C, Grebow PE. Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol 1998; 38:971–978. [INFOTRIEVE], [CSA]
- Wong YN, King SP, Laughton WB, McCormick GC, Grebow PE. Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers. J Clin Pharmacol 1998; 38:276–282. [INFOTRIEVE], [CSA]